Latest Ketones Stories
DUBLIN, Dec. 15, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it is filing an emergency appeal to the U.S.
DALLAS, December 12, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Opioids Market Overview to 2023 - Opioids in Emerging Markets" industry research report with latest
Website and Mobile App Offer Comprehensive Array of Information and Resources to Support Patients and Their Families RALEIGH, N.C., Dec.
CORALVILLE, Iowa, Dec.
First-in-class treatment approved for adult patients with opioid-induced constipation who have had an inadequate response to laxatives SAN FRANCISCO, Dec.
- New Express Scripts report provides nation's most comprehensive analysis of pain treatment trends. ST. LOUIS, Dec.
Data presented from largest combination buprenorphine/naloxone opioid dependence trial ever conducted in the U.S. MORRISTOWN, N.J., Dec. 6, 2014 /PRNewswire/ -- Orexo US, Inc.
Lightlake Therapeutics advances collaboration with NIDA for novel intranasal naloxone application to reverse opioid overdose LONDON, Dec.
Pain Insights, Inc.
More Images (1 images) »